Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management (NCT03738566) | Clinical Trial Compass
CompletedNot Applicable
Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management
United States26 participantsStarted 2018-11-21
Plain-language summary
This study is being done to see which treatment is more effective in improving the difficulty of swallowing. Researchers are comparing self-dilation to endoscopic dilation.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Refractory benign esophageal stricture defined as an esophageal stricture with persistent dysphagia despite undergoing 5 endoscopic dilations within a 1 year period. Persistent dysphagia will be considered if patients has solid food dysphagia at least once a week
Exclusion Criteria:
* Patient with malignant esophageal stricture
* Angulated stricture which prevents safe passage of Maloney dilator in office setting
* In ability to achieve an esophageal diameter of 10 mm with endoscopic dilation
* Known significant esophageal motor disorder (i.e. achalasia, aperistalsis, functional obstruction, jackhammer, distal esophageal spasm)\*
* The presence of esophageal stent
* Inability to learn self-dilation secondary to blindness or cognitive dysfunction
* Use of chronic anticoagulants